MigraineMind research summary
Headache in mitochondrial diseases: From migraine to stroke-like episodes.
Headache | 2026
ReviewSummary
Headaches in primary mitochondrial diseases (PMDs) have unique features needing differentiation. These headaches affect about 55% to 71% of PMD patients. Individuals with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) experience higher rates. Migraine prevalence in PMD patients is three to four times higher than average. A narrative literature review examined headaches across PMDs. Researchers searched databases like PubMed and Scopus for relevant studies. Migraine, with or without aura, is the most common headache type in PMDs. This is especially true for carriers of the m.3243A>G mutation. Recent studies suggest a potential link between low mitochondrial DNA and migraine. Characteristics of PMD headaches include atypical aura and co-occurring neurological symptoms. Mitochondrial cofactors like riboflavin and coenzyme Q10 may aid treatment. Specialized approaches are necessary for effective headache management in PMDs. Evaluation for mitochondrial disease is advised with atypical migraine features. Clinical relevance: This research highlights the need for specialized headache management in mitochondrial diseases.
Key Learning Points
- Headaches are common in primary mitochondrial diseases, affecting 55% to 71% of patients, making it a significant concern for management.
- Migraine is the most prevalent headache type in patients with mitochondrial diseases, occurring at rates three to four times higher than in the general population.
- Patients with MELAS experience even higher rates of headaches, indicating a need for tailored treatment approaches.
- Atypical aura and additional neurological symptoms often accompany headaches in mitochondrial diseases, necessitating careful evaluation.
- Treatment options may include mitochondrial cofactors like riboflavin and coenzyme Q10, highlighting the importance of specialized management strategies.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.